Stenting ± abciximab more effective in acute MI

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1332, 2002-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A multiple stenting strategy is "more safe and cost-effective" than hybrid stenting

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Stenting worth it, but value of abciximab uncertain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Stenting worth it, but value of abciximab uncertain

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Coronary stenting "highly cost-effective" vs alteplase in MI

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Coronary stenting "highly cost-effective" in MI vs alteplase

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite